Hansen, A. R., Borgwardt, L., Rasmussen, Å. K., Godballe, C., Godballe, C., Poulsen, M. M., . . . Rossing, M. (2021). Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2. Frontiers Media S.A.
Chicago Style (17th ed.) CitationHansen, Anna Reimer, et al. Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2. Frontiers Media S.A, 2021.
MLA (8th ed.) CitationHansen, Anna Reimer, et al. Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2. Frontiers Media S.A, 2021.
Warning: These citations may not always be 100% accurate.